Neil Bhowmick insider trades
Open-market stock purchases and sales by Neil Bhowmick, Chief Scientific Officer at Kairos Pharma, Ltd, from SEC Form 4 filings since Jan 1, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 8, 2025 | KAPA Kairos Pharma, Ltd | Bought (not open market) | — |
Companies traded
- KAPA Kairos Pharma, Ltd: other filings, last Oct 8, 2025